A prospective randomized trial to evaluate different oral dose regimens of medroxyprogesterone acetate in women with advanced breast cancer

This publication has 15 references indexed in Scilit:

• High-dose progestin therapy for metastatic breast cancer
  Annals of Oncology, 1992
• A multicentre trial to compare a loading dose regimen of tamoxifen (‘nolvadex’) with conventional dosing in the treatment of advanced breast cancer
  Clinical Oncology, 1991
• Randomized Trial Comparing Aminoglutethimide With High-Dose Medroxyprogesterone Acetate in Therapy for Advanced Breast Carcinomau
  JNCI Journal of the National Cancer Institute, 1988
• The pharmacokinetics of medroxyprogesterone acetate following two different loading dose schedules in advanced carcinoma of the breast
  British Journal of Cancer, 1988
• High dose versus low dose medroxyprogesterone acetate: a randomized trial in advanced breast cancer
  European Journal of Cancer and Clinical Oncology, 1987
• Lack of correlations between plasma concentration of medroxyprogesterone acetate, hypothalamic-pituitary function, and tumour response in patients with advanced breast cancer
  Cancer Chemotherapy and Pharmacology, 1985
• An evaluation of high-dose medroxyprogesterone acetate (MPA) therapy in women with advanced breast cancer
  British Journal of Cancer, 1984
• Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer
  Published by Elsevier ,1979
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
  British Journal of Cancer, 1977
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958